Clinical Trial Update: A Pilot Study to Characterize the Pharmacokinetics of Raltegravir in the Cervicovaginal Fluids of HIV-infected Women

View source ↗

Summary

This clinical trial update reports findings from a pilot study characterizing how raltegravir distributes in cervicovaginal fluids of HIV-infected women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Raltegravir (raltegravir)

Snippet

Sponsor: Kristine Patterson, MD | Conditions: HIV, AIDS | Status: COMPLETED